Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10014326HBVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS30086512HIVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS20022380HPVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS20049966HPVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS20049934HPVENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS44013458HTLV-1ENSG00000082175.16protein_codingPGRYesNo5241P06401
TVIS44020347HTLV-1ENSG00000082175.16protein_codingPGRYesNo5241P06401
TCGA Plot Options
Drug Information
GenePGR
DrugBank IDDB01406
Drug NameDanazol
Target IDBE0000557
UniProt IDP06401
Regulation Typeagonist
PubMed IDs17636649; 18061638; 8000225; 2404115
CitationsBeaumont H, Augood C, Duckitt K, Lethaby A: Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001017.@@Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, Kato S, Mizuguchi K: Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids. 2008 Feb;73(2):222-31. Epub 2007 Oct 22.@@Huang HF, Wang M: [Effects of gossypol acetate, danazol, progesterone and GnRH-A on estrogen and progesterone receptors of human endometrial cells]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1994 Jun;14(6):352-3, 325.@@Dmowski WP: Danazol. A synthetic steroid with diverse biologic effects. J Reprod Med. 1990 Jan;35(1 Suppl):69-74; discussion 74-5.
GroupsApproved
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
Pathways
PharmGKBPA164749056
ChEMBLCHEMBL1479